Shi, M., Lai, Z., He, M., Kan, A., Ge, A., Wu, Z. (2026). Hepatic arterial infusion chemotherapy plus either toripalimab or sorafenib as first-line therapy for non–high-risk, locally advanced hepatocellular carcinoma: A non-comparative, randomized phase 2 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4115